Research & News

Efficacy of 4 Week Program of Neonatal ARVs

May 19, 2011

Irish researchers showed that a four-week course of infant ARVs was as effective in preventing vertical transmission of HIV as a six-week course. Transmission rate amongst subjects (N=916) was 1.09%. Additionally, if the mother received at least four-weeks of ARVs as well... Read More

Nevirapine Resistance in HIV-infected Infants

May 19, 2011

Infants in low-resource settings are often treated with nevirapine to prevent HIV transmission. The PEPI-Malawi study showed that those infants treated with 14 weeks of nevirapine showed high rates of resistance to the drug that persisted for up to twelve months. Those... Read More

Viral Loads Postpartum in HIV-Infected Women

May 19, 2011

The AIDS Clinical Trials Group (ACTG) A5150 team saw significant increases in viral loads in women by 24-weeks postpartum. These women were on HAART for perinatal prevention during their pregnancy. Amongst those who changed or discontinued their HAART postpartum, 52.6%... Read More

CDC Enhanced Perinatal Surveillance Report

May 04, 2011

The CDC's Enhanced Perinatal Surveillance report (2005-2008) provides information on those women who are HIV-infected and gave birth between 2005 and 2008 in 15 jurisdictions in the United States. The Enhanced Perinatal Surveillance (EPS) program was designed to elicit... Read More

Previous ARV Exposure Does Not Impede PI-Based Treatment in Pregnant Women

Apr 25, 2011

Data from the French Perinatal Cohort provide reassurance that women previously treated with antiretroviral therapy were not adversely affected during protease inhibitor based treatment during pregnancy. However, the percentage of women with undetectable viral load at... Read More

New Estimates of Number of Infants Born to HIV-Infected Women

Apr 25, 2011

New data on the number of HIV-exposed infants born in the U.S. estimates 9,000 infants were born in 2006. This is an increase of up to 30% as compared to the estimate of infants born in 2000. The authors suggest this increase is likely reflective of an overall increase in... Read More

HIV PrEp Trial in Women Halted

Apr 24, 2011

Preliminary data from the FEM-PrEP trial show equal numbers of HIV infection in women taking Truvada as those taking placebo. The trial has been stopped because it is highly unlikely to show that Truvada offers women protection against HIV infection. To learn more, click... Read More

Pregnancy Incidence Lower Among HIV-Infected Women

Mar 14, 2011

Results recently published from the ongoing Women's Interagency HIV Study (WIHS) reveal that pregnancy incidence among HIV-infected women remains lower despite the beneficial effects of modern antiretroviral therapy. The study authors conclude that whether lower incidence... Read More

Estimated Number of HIV-Exposed Infants Born in US

Mar 14, 2011

This study aimed to estimate the number of infants born to HIV-infected women in the U.S. and its dependencies in 2006. The estimated number of births in 2006 to all women living with HIV (diagnosed or undiagnosed) was 8,700. This number is approximately 30% greater than... Read More

Premastication and Risk for HIV Transmission

Mar 10, 2011

The CDC looked at premastication (pre-chewing) food for infants by caregivers across nine HIV-clinic sites to determine the prevalence of this practice. Rates were as high as 31% of caregivers who stated they had premasticated food for HIV-exposed children ages 1-6. Rates... Read More

Pages